Skip to main content

osiris-therapeutics

Osiris has a history of developing treatments — like Prochymal, the first government-approved stem cell drug — and then selling them to other companies. Its product portfolio is thus diverse, and that is wise when it comes to Grafix, which competes with a number of other advanced wound care products.

{iframe}http://www.bizjournals.com/baltimore/print-edition/2014/11/07/columbia-s-osiris-taps-stem-cells-to-build-a.html{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.